TP53 and endometrial endometrioid carcinoma: Stewart et al. demonstrated that 18 endometrioid endometrial carcinoma patients showed diffuse or focal p53 expression in immunohistochemistry, whereas direct sequencing for exon 5–10 of TP53 detected no mutations in any of the 18 patients [76].